Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Ben Westphalen, Oncologist with a specialization in Precision Oncology and Serving as chair of the Precision Medicine Working Group at European Society for Medical Oncology, shared an article by Ivone U.S. Leong post on X:
“The power of Big Data in this Open Access research paper in Journal of Clinical Oncology.
Data from the 100,000 Genomes Project suggests that reporting pharmacogenetic (PGx) variants + cancer WGS data could guide safer prescribing.”
Authors: Ivone U.S. Leong, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18